Literature DB >> 22085160

Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients.

T De Broucker1, A Mailles, S Chabrier, P Morand, J-P Stahl.   

Abstract

Varicella zoster virus (VZV) is a leading cause of acute viral encephalitis but little is known about its clinical, biological and imaging features. Furthermore, the most favourable treatment regimen has not been determined. We studied a prospective cohort of 20 HIV-negative patients presenting with acute VZV encephalitis caused by primary infection or reactivation. VZV was identified in 16 of 20 cases by PCR detection of the DNA in the cerebrospinal fluid. The four remaining cases occurred during or soon after a VZV rash. The median age of the 17 adults was 76 (19-86) years; the three other patients were children (0.5-5 years). Three patients were immunocompromised. Nine adult patients presented with a rash. Eighteen patients presented with fever and an acute encephalitic syndrome: diffuse brain dysfunction, focal neurological signs, seizures and cranial nerve palsies. Three patients presented with either ventricular or subdural haemorrhage, one with myelitis, and one with asymptomatic stenosis of the middle cerebral artery. The imaging was either normal or revealed non-specific abnormalities such as cortical atrophy but no evidence of stroke. All patients were given acyclovir at various dosages and durations but the case fatality rate remained high (15%) and sequelae were frequently observed either at discharge or at follow-up 3 years later.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085160     DOI: 10.1111/j.1469-0691.2011.03705.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  24 in total

Review 1.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

2.  Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report.

Authors:  E M Rodenburg; F H Vermeij; M J van den Bent; J M Zuetenhorst
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

3.  Focal herpes zoster encephalitis without a rash: diagnostic confusion between astrogliosis and low-grade glioma.

Authors:  Geoffrey C Halling; Charles Grose
Journal:  Expert Rev Anti Infect Ther       Date:  2016-10-27       Impact factor: 5.091

4.  Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.

Authors:  Avindra Nath; Joseph R Berger
Journal:  Curr Treat Options Neurol       Date:  2012-06       Impact factor: 3.598

5.  Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.

Authors:  Anna Grahn; Lars Hagberg; Staffan Nilsson; Kaj Blennow; Henrik Zetterberg; Marie Studahl
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

Review 6.  Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.

Authors:  Marie Studahl; Lars Lindquist; Britt-Marie Eriksson; Göran Günther; Malin Bengner; Elisabeth Franzen-Röhl; Jan Fohlman; Tomas Bergström; Elisabeth Aurelius
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

7.  Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium.

Authors:  A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser
Journal:  Clin Infect Dis       Date:  2013-07-15       Impact factor: 9.079

8.  Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).

Authors:  M Arruti; L D Piñeiro; Y Salicio; G Cilla; M A Goenaga; A López de Munain
Journal:  J Neurovirol       Date:  2017-02-21       Impact factor: 3.739

9.  A study on viral CNS inflammation beyond herpes encephalitis.

Authors:  Berit Jordan; Sabrina Kösling; Alexander Emmer; Antje Koch; Tobias Müller; Malte Kornhuber
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 3.739

10.  Cognitive impairment 3 years after neurological Varicella-zoster virus infection: a long-term case control study.

Authors:  Anna Grahn; Staffan Nilsson; Arto Nordlund; Thomas Lindén; Marie Studahl
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.